Preston
MBow30 alt account
Study on a South Korean vaccine currently in Phase 3 trials. It is RBD-based which is different than anything currently out and the hope was that it would provide more variant-proof protection. Looks like it does after a booster.
www.biorxiv.org
This part in particular was interesting. Peak responses may not be too different from Moderna's but durability on this platform appears to be much stronger.

Long lasting immunity is gonna be a big piece of the puzzle. None of this 2-3 month shit.

Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
Despite the remarkable efficacy of COVID-19 vaccines, waning immunity, and the emergence of SARS-CoV-2 variants such as Omicron represents a major global health challenge. Here we present data from a study in non-human primates demonstrating durable protection against the Omicron BA.1 variant...
This part in particular was interesting. Peak responses may not be too different from Moderna's but durability on this platform appears to be much stronger.

Long lasting immunity is gonna be a big piece of the puzzle. None of this 2-3 month shit.